Perrigo
PRGO
#5384
Rank
โ‚น140.86 B
Marketcap
โ‚น1,018
Share price
-2.12%
Change (1 day)
-54.95%
Change (1 year)

Revenue for Perrigo (PRGO)

Revenue in 2025 (TTM): โ‚น372.05 Billion

According to Perrigo's latest financial reports the company's current revenue (TTM ) is โ‚น408.10 Billion. an increase over the revenue in the year 2024 that were of โ‚น375.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Perrigo from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น381.79 B1.76%
2024 โ‚น375.17 B-3.2%
2023 โ‚น387.56 B5.21%
2022 โ‚น368.37 B19.58%
2021 โ‚น308.04 B-2.6%
2020 โ‚น316.27 B-8.32%
2019 โ‚น344.95 B4.26%
2018 โ‚น330.85 B4.76%
2017 โ‚น315.82 B-7.91%
2016 โ‚น342.95 B-3.54%
2015 โ‚น355.54 B34.48%
2014 โ‚น264.38 B12.64%
2013 โ‚น234.72 B31.4%
2012 โ‚น178.63 B14.1%
2011 โ‚น156.56 B38.88%
2010 โ‚น112.73 B14.34%
2009 โ‚น98.59 B2.73%
2008 โ‚น95.96 B57.28%
2007 โ‚น61.01 B-1.47%
2006 โ‚น61.92 B12.43%
2005 โ‚น55.08 B37.83%
2004 โ‚น39.96 B3.94%
2003 โ‚น38.44 B-2.37%
2002 โ‚น39.38 B0.27%
2001 โ‚น39.27 B17.23%
2000 โ‚น33.50 B-9.57%
1999 โ‚น37.04 B-0.59%
1998 โ‚น37.26 B8.34%
1997 โ‚น34.39 B18.75%
1996 โ‚น28.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
United Therapeutics
UTHR
โ‚น305.39 B-25.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
โ‚น193.01 B-52.70%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น30.48 B-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
โ‚น424.31 B 3.97%๐Ÿ‡บ๐Ÿ‡ธ USA